Skip to main content
. 2021 Jul 19;473(8):1261–1271. doi: 10.1007/s00424-021-02576-5

Fig. 3.

Fig. 3

GABABR agonist-induced and antagonist-induced effects on eIPSCs. a Representative eIPSC traces recorded from a WT (top) and Tsc2+/- (bottom) cell in control and in the presence of either baclofen (10 µM) or CGP55845 (1 µM). Traces are an average of 20 consecutive recordings. b Mean eIPSC amplitudes are not significantly different in WT and Tsc2+/- neurons. c Baclofen reduces the mean eIPSC amplitude stronger in Tcs2 ± cells compared with WT neurons (left), whereas CGP55845 increases the mean eIPSC amplitude in WT cells but not in Tsc2+/- neurons (right panel). d In the presence of CGP55845 (CGP), the paired-pulse ratio at 500 ms interstimulus interval (PPR500) is reduced in WT neurons (left) but increased in Tsc2+/- ones (right panel)